Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Nov 15;16(6):807-808.
doi: 10.5009/gnl220414.

Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant Helicobacter pylori Infection: Effectiveness and Cost-Efficiency

Moon Won Lee  1 , Gwang Ha Kim  1
Affiliations
Editorial

Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant Helicobacter pylori Infection: Effectiveness and Cost-Efficiency

Moon Won Lee et al. Gut Liver. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

G.H.K. is an editorial board member of the journal but was not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.

Comment on

References

    1. Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112:212–239. doi: 10.1038/ajg.2016.563. - DOI - PubMed
    1. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence consensus report. Gut. 2017;66:6–30. doi: 10.1136/gutjnl-2016-312288. - DOI - PubMed
    1. Lee JH, Ahn JY, Choi KD, et al. Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: a prospective multicenter study. Helicobacter. 2019;24:e12592. doi: 10.1111/hel.12592. - DOI - PubMed
    1. Seo SI, Lim H, Bang CS, et al. Bismuth-based quadruple therapy versus metronidazole-intensified triple therapy as a first-line treatment for clarithromycin-resistant Helicobacter pylori infection: a multicenter randomized controlled trial. Gut Liver. 2022;16:697–705. doi: 10.5009/gnl210365. - DOI - PMC - PubMed
    1. Jung HK, Kang SJ, Lee YC, et al. Evidence-based guidelines for the treatment of Helicobacter pylori infection in Korea 2020. Gut Liver. 2021;15:168–195. doi: 10.5009/gnl20288. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources